Treatment of Patients With Diabetic Kidney Disease
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Due to irrespective of the limitations associated with estimated glomerular filtration rate
(eGFR), it is crucial to develop new treatments that can effectively address these concerns.
So, this study aimed to compare the effectiveness of SGlT2i versus ACEi in the progression of
diabetic kidney disease including progression of albuminuria. Doubling of serum creatinine
and need for renal replacement therapy